Shoko Ueda

Osaka University of Pharmaceutical Sciences

Papers

3

Total Citations

13

H-Index

2

About

Shoko Ueda is a rising surgical oncologist specializing in gynecologic malignancies, with a focused research program on optimizing surgical approaches for early-stage cervical and endometrial cancers. Her work critically evaluates the trade-offs between minimally invasive surgery (MIS) and traditional open techniques. In her most cited study (2022, 8 citations), she compared prognosis after MIS versus abdominal radical hysterectomy for early-stage cervical cancer, contributing to the ongoing debate sparked by recent evidence linking MIS to higher recurrence rates. Ueda has also pioneered technical innovations, including a robot-assisted modified radical hysterectomy that incorporates indocyanine green for sentinel lymph node mapping and lymphatic vessel removal (2022, 3 citations), emphasizing safety in endometrial cancer treatment. Her most recent work (2024, 2 citations) extends this line of inquiry by examining oncologic outcomes after sentinel lymph node biopsy in cervical cancer, a procedure whose prognostic value remains under investigation. Through these contributions, Ueda is helping to refine surgical standards, balancing the benefits of reduced invasiveness with the imperative of oncologic safety.

Research Focus

Key Achievements

2
H-Index
3
Papers
13
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer
8 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Osaka University of Pharmaceutical Sciences

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago